Advertisement
Australia markets closed

  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     

  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     

  • AUD/USD

    0.6609
    -0.0012 (-0.19%)
     

  • OIL

    79.80
    +0.54 (+0.68%)
     

  • GOLD

    2,378.90
    +38.60 (+1.65%)
     

  • Bitcoin AUD

    95,556.96
    +3,081.80 (+3.33%)
     

  • CMC Crypto 200

    1,304.16
    -53.85 (-3.97%)
     

  • AUD/EUR

    0.6129
    -0.0009 (-0.15%)
     

  • AUD/NZD

    1.0983
    +0.0015 (+0.13%)
     

  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     

  • NASDAQ

    18,113.46
    +28.46 (+0.16%)
     

  • FTSE

    8,445.92
    +64.57 (+0.77%)
     

  • Dow Jones

    39,387.76
    +331.36 (+0.85%)
     

  • DAX

    18,786.97
    +100.37 (+0.54%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Creating and Protecting IP Value in Connection with VC Financings

TC Video
Updated

How do venture capital investors value formal Intellectual Property (IP) rights in connection with a decision to fund a technology or life sciences start-up? How do they conduct IP due diligence? How do investors and founders, post-funding, ensure their start-ups are pursuing an IP strategy that optimizes exit valuation for all? Perkins Coie partners Michael Glenn (Patent Prosecution) and Matt Oshinsky (Emerging Companies Venture Capital) will be joined alongside a seasoned venture capitalist to discuss these and other questions regarding safeguarding IP rights and maximizing the value of all technology development activities.